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In utero exposure to selected anti-epileptic drugs (AEDs) 
has an established association with adverse outcomes in 
exposed offspring. However, since the majority of women 
with epilepsy still require on-going treatment with AEDs 
during pregnancy, quantifying the risk of related adverse 
events as well as identifying potential modulating factors 
remain highly relevant. Although the teratogenic effects of 
valproate are now widely recognised, there remains a need to 
clarify risks of long-term intellectual impairment in children 
exposed to AEDs in general and to understand any underly-
ing mechanisms of action.
This month’s journal club reviews three papers which 
explore the use of anti-epileptic drugs in pregnancy. The 
first is a large, national, population-based study exploring 
association between AED exposure and performance in lan-
guage and mathematics tests in school-aged children. The 
second examines the relationship between folic acid levels 
and verbal ability in offspring of mothers with epilepsy and 
the third provides an insight into potential biological mecha-
nisms by considering the action of valproate on the placenta.
Association between prenatal valproate 
exposure and performance on standardized 
language and mathematics tests 
in school‑aged children
In this study, the core data were provided by Statistics 
Denmark which then allowed linkage across a selection of 
national registers, and for information on several domains to 
be collated on a large number of children. All live births in 
Denmark between 1997 and 2006 were identified. Children 
with missing information on performance in national tests or 
other covariates were excluded. Medical exposure to AEDs 
was defined as 30 days from the first day of the last men-
strual cycle to 1 day before birth. The main outcome of the 
study was performance in National tests in Danish and math-
ematics. The results of all tests completed between 2010 and 
2014 were presented as standard deviations from the mean (z 
scores) for comparison. Scores were adjusted for covariates 
including sex, calendar year, mother’s educational level and 
household income.
A total of 479,027 children were included, of whom 253 
were exposed to sodium valproate as monotherapy, 396 to 
lamotrigine, 294 to carbamazepine, 236 oxcarbazepine, 86 
phenobarbital and 188 to clonazepam. Children exposed 
to valproate monotherapy performed significantly worse 
than AED-unexposed children, even when outcomes were 
adjusted for socioeconomic factors. However, there was no 
significant difference in the test results of children exposed 
to lamotrigine or alternative AEDs when compared to unex-
posed children.
Comment. Strengths of this study include the large study 
population, access to accurate and well-curated datasets 
from the Danish registry system and the ability to compare 
standardized test results over a 4-year period. The authors 
concede that missing information regarding folic acid use 
is a limitation, and also point out that children attending 
private schools were not included in the study, as they did 
not participate in national tests. Further limitations include 
the difficulty of adequate adjustment for the complex soci-
oeconomic covariates which influence a child’s school 
performance.
Despite these issues, this is a large and robust study which 
supports previous observations of the association of prena-
tal valproate exposure with poorer school performance, but 
does not see these adverse effects in a range of alternative 
AEDs and also supports the use of lamotrigine as a safer 
alternative.
Skou Elkjaer et  al. (2018) JAMA Neurology 
75(6):633–671.
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Verbal abilities in children of mothers 
with epilepsy: association to maternal folate 
status
Folate is a type of vitamin B whose deficiency has been 
associated with neural tube defects. Many AEDs interact 
with folate metabolism and as a result women with epilepsy 
are advised to take folic acid supplements during pregnancy. 
Recent research has also linked folate deficiency with autism 
and lower intellectual ability in offspring.
This prospective, epidemiological study investigated 
the effect of maternal folic acid supplementation, maternal 
plasma folate levels and anti-epileptic drug concentrations on 
verbal ability in AED-exposed children. The study popula-
tion consisted of participants in the Norwegian Mother and 
Child Cohort Study which is an on-going population-based 
study conducted by the Institute of Public Health. Parent-
completed questionnaires on background, medical history, 
folic acid intake and child development were completed at 
17–19 weeks’ gestation, 30 weeks’ gestation and at age 18 
and 36 months. Blood samples were also collected from the 
mother at weeks 17–19 of pregnancy and from the umbilical 
cord immediately after delivery. Covariates included parental 
higher education, total household income, unplanned preg-
nancy, smoking and alcohol intake. Data were analysed from 
three groups: AED-exposed children born to mothers with 
epilepsy, AED-unexposed children born to mothers with epi-
lepsy and children of mothers without epilepsy. Groups were 
further sub-divided according to folic acid supplementation.
In the AED-exposed group without folate supplementa-
tion 34% and 24% had global language delay at 18 months 
and 36 months, respectively, compared to 11% and 6% in 
the control group without epilepsy. In the AED-exposed 
children of mothers with epilepsy who had taken folic acid, 
17% had global language delay at 18 months. Furthermore, 
the number of lamotrigine-exposed children with language 
delay was higher in the group without folic acid supple-
mentation compared to the group that had received supple-
ments. Higher maternal plasma valproate concentration cor-
related significantly with a lower global language score at 
age 18 months. However, no correlation between folate dose 
or concentration and verbal ability was identified.
Comment. This study involves a large dataset, effective 
validation of maternal diagnosis of epilepsy and appropri-
ate attempts to adjust for confounding factors. However, 
there are some limitations which include potential sub-
optimal timing of blood tests for folate and AED levels at 
17–19 weeks’ gestation rather than the first trimester. Nev-
ertheless, this study convincingly demonstrates a protective 
effect of folic acid supplementation on language develop-
ment in AED-exposed children. This clinically relevant 
observation is in keeping with previous research; however, 
more information on the effect of folate supplementation on 
children exposed to lamotrigine would be informative.
Husebye et al. (2018) Neurology 91(9):e811–e821.
Adverse placental effects of valproic acid: 
studies in perfused human placentas
This paper explores the effect of short exposure to valp-
roic acid on placental expression of transporters for com-
pounds essential for foetal development. Placentas were 
obtained from term caesarean deliveries of women without 
a known diagnosis of epilepsy. Cotyledons were cannulated 
and perfused in the absence or presence of valproic acid at 
therapeutic (42 µg/ml and 83 µg/ml; n = 6/group) and supra-
therapeutic (166 µg/ml; n = 6) concentrations for 180 min. 
Expression of genes for various transporters was analysed 
in the cotyledons after this time period.
The study demonstrated that exposure to valproic acid 
results in significant down-regulation of gene expression 
of important placental transporters, in particular, FOLR1 
which encodes the folate receptor alpha and SLC2A1 and 
GLUT1 which encode glucose carriers. Folate concentra-
tions within placental tissue exposed to valproic acid were 
reduced by 25–35% compared to the control group, although 
did not reach significance (p = 0.059). Up-regulation of the 
SLC6A4 gene which encodes the serotonin receptor was also 
observed and may be of relevance as high levels of serotonin 
have previously been linked to autism.
Comment. This study is one of the few to explore the 
effects of sodium valproate on the human placenta. The 
study was designed to imitate in utero conditions includ-
ing pH and oxygen tensions. Limitations include the use of 
placentas collected at term and for a short time interval of 
180 min. It has been suggested that the adverse effects of 
valproic acid are more likely to take place in early pregnancy 
within a more complex biological setting and over a consid-
erably longer time period.
Rubinchik-Stern et al. (2018) Epilepsia 59:993–1003.
Conclusion. The results of these studies support recent 
evidence that valproate is associated with poorer educational 
attainment and reiterates the importance of peri-conceptual 
folic acid supplementation. Whilst the first paper has proposed 
lamotrigine as a safer drug in terms of long-term school per-
formance, the second study found an association between lam-
otrigine-exposed children of mothers who had not taken peri-
conceptual folic acid and language delay. With the increasing 
availability of newer AEDs, including levetiracetam, and their 
preferential use in pregnancy above some of the traditional 
agents, further research to establish data of adverse events in 
offspring of mothers with epilepsy is needed.
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